Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ripin

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Viruses|October 29, 2025
An Intranasal Challenge Model in African Green Monkeys (<i>Chlorocebus aethiops</i>) for Mild-to-Moderate COVID-19 Disease Caused by Subvariant XBB.1.5Nadia Storm, Ming Lo, Nicholas Crossland, et al.
The Lancet. HIV|February 9, 2020
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelinesAndrew N Phillips, Loveleen Bansi-Matharu, Francois Venter, et al.
Journal of Medicinal Chemistry|September 2, 2005
Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinaseKim F McClure, Yuriy A Abramov, Ellen R Laird, et al.
The Lancet. HIV|January 15, 2023
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling studyJennifer Smith, Loveleen Bansi-Matharu, Valentina Cambiano, et al.
Nucleic Acids Research|April 10, 2025
High-throughput screen of 100 000 small molecules in C9ORF72 ALS neurons identifies spliceosome modulators that mobilize G4C2 repeat RNA into nuclear export and repeat associated non-canonical translationMaartje J Luteijn, Varun Bhaskar, Dominic Trojer, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Viruses|October 29, 2025
An Intranasal Challenge Model in African Green Monkeys (<i>Chlorocebus aethiops</i>) for Mild-to-Moderate COVID-19 Disease Caused by Subvariant XBB.1.5Nadia Storm, Ming Lo, Nicholas Crossland, et al.
The Lancet. HIV|February 9, 2020
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelinesAndrew N Phillips, Loveleen Bansi-Matharu, Francois Venter, et al.
Journal of Medicinal Chemistry|September 2, 2005
Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinaseKim F McClure, Yuriy A Abramov, Ellen R Laird, et al.
The Lancet. HIV|January 15, 2023
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling studyJennifer Smith, Loveleen Bansi-Matharu, Valentina Cambiano, et al.
Nucleic Acids Research|April 10, 2025
High-throughput screen of 100 000 small molecules in C9ORF72 ALS neurons identifies spliceosome modulators that mobilize G4C2 repeat RNA into nuclear export and repeat associated non-canonical translationMaartje J Luteijn, Varun Bhaskar, Dominic Trojer, et al.
Pageof 10